Business / Finance

RSS

Arena fourth quarter net loss decreases to $28.2 million

Arena Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2010, and reviewed recent developments.

11 Mar 2011

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.

11 Mar 2011

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

11 Mar 2011

Synta fourth-quarter total collaboration revenue decreases to $3.0 million

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported fourth-quarter and full-year 2010 financial results, provided an update on recent progress with its programs, and announced 2011 objectives.

11 Mar 2011

BioScrip fourth quarter revenue increases 31.9% to $450.4 million

BioScrip, Inc. today announced 2010 fourth quarter and year-end financial results. Fourth quarter revenue was $450.4 million with a net loss of $67.1 million, or $1.25 per share, which included a deferred-tax asset valuation allowance expense of $54.0 million and $9.2 million of litigation, restructuring, integration, acquisition, severance and CAP bad debt expense.

11 Mar 2011

Centric Health 2010 revenue increases 70% to $62.5 million

Centric Health Corporation, Canada's leading diversified healthcare services company, today announced financial results for the fourth quarter and year ended December 31, 2010.

11 Mar 2011

BDSI prices $15 million private placement

BioDelivery Sciences International, Inc. announces that it has received definitive commitments from institutional investors for a private placement financing yielding gross proceeds of $15 million to BDSI. The financing is expected to close today.

11 Mar 2011

DiagnoCure first quarter total revenue is $362,101 for 2011

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter of fiscal 2011.

11 Mar 2011

Walgreens sells Pharmacy Benefits Manager to Catalyst Health Solutions

Catalyst Health Solutions Inc said it will buy Walgreen Co's pharmacy benefits management unit for about $525 million in cash, a deal that might spur more consolidation before big generic drug launches that could boost the business.

11 Mar 2011

Cardiome total revenue for fiscal 2010 is $66.1 million

Cardiome Pharma Corp. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Biothera announces acquisition of AS1402 anti-cancer monoclonal antibody from Antisoma

Biothera announced today that it has acquired the anti-cancer monoclonal antibody AS1402 from Antisoma for undisclosed terms.

10 Mar 2011

Oncothyreon 2010 net loss decreases to 15.6 million

Oncothyreon Inc. today reported financial results for the year and quarter ending December 31, 2010.

10 Mar 2011

Columbia fourth quarter total net revenues increase 74% to $14.9 million

Columbia Laboratories, Inc. today reported financial results for the three- and twelve-month periods ended December 31, 2010.

10 Mar 2011

China Health Labs & Diagnostics begins trading on OTCQX International

China Health Labs & Diagnostics Ltd., is pleased to announce that effective March 10, 2011 its shares began trading on the OTC Market's premier tier, OTCQX International, under the symbol CHLBF.

10 Mar 2011

Northstar fourth quarter net patient service revenue decreases to $2.2 million

Northstar Healthcare Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Medtronic resolves FDA warning letters over Mounds View, Juncos facilities

Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters -- one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico -- have been resolved.

10 Mar 2011

Medtronic opens new manufacturing facility in Singapore

Medtronic, Inc., the global medical technology leader, announced today the official opening of its new manufacturing facility, Medtronic Singapore Operations. The facility will enhance the company's manufacturing capabilities to meet the future expected growth of cardiac devices in Asia.

10 Mar 2011

NextGen Group subsidiary completes commercial reorganization

NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.

10 Mar 2011

Alliance fourth quarter revenue decreases to $117.7 million

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced results for the fourth quarter and year ended December 31, 2010.

9 Mar 2011